Doctors Name: Diana Maria Prince
License Number: 63605
License Status:
Current - (Dues Paid)
Accusation Filed
City of Record: Rohnert Park
Region: Northern
License issued on: 10/03/1997
Licensing Boards: Medical
Specialties :
General/Family Practice
Gender: Female
Accusations and Infractions or Causes for Discipline:
Unprofessional Conduct
Repeated Negligent Acts
Gross Negligence
Prescribing Without Medical Exam
Date of Last MBC Action: 11/20/2018
Repeat Offender:
No
Ongoing Discipline:
Yes
Out of State Discipline:
No
No Medical Board Activity:
_____________________________________________________________________________________________________
Medical Board Documents, News Articles, Court Documents, Etc.
| Accusation 11/20/2018 | |
______________________________________________________________________________________________________
Additional Information (Medical School, Dated Actions, Excerpts from Disciplinary Actions, Notes)STANFORD UNIVERSITY SCHOOL OF MEDICINE
BACKGROUND FACTS
8. At all times relevant to this matter, Respondent was a Family Practice Physician working at the Kaiser Permanente Medical Group.
9. Beginning in April 2009 and continuing to 2012, Respondent treated Patient P-12 for various medical complaints, including, primarily, chronic pain from degenerative lumbar disc disease, anxiety, depression and grief. Respondent initially performed a physical examination, and prescribed Carisoprodol, Oxybutynin Chloride, Morphine, Promethazine, and Hydrocodone-Acetaminophen. Thereafter, Patient P-1 and Respondent communicated mostly by email or telephone call. Patient P-1 requested, and Respondent prescribed, potent opioids such as Percocet (also known as. Endocet or Oxycodone-Acetaminophen) for her breakthrough pain. Patient P-1 frequently requested early refills of medications.
10. By August 2009, Patient P-1 complained of anxiety and requested Xanax. Although Respondent informed Patient P-1 that it is "very dangerous to mix with opiate pain medication and I am not sure this is the best option", she nevertheless began to prescribe Xanax. Antidepressant medication was added, and over time, Patient P-1's life spiraled out of control as she lost her job and health insurance, and her husband died. Throughout 2009-2010, Respondent continued to prescribe large quantities of Xanax and Percocet, usually without seeing Patient P-1, and in spite of red flags such as requests for early refills and the patient acknowledging she was taking her medication in amounts greater than prescribed.
11. In an April 2010 email, Respondent noted to Patient P-1 that she was taking more than 5 Xanax per day and that Respondent was "completely terrified" by that, and that Respondent was "creating a person who is WAY overusing these medications." She further stated that "I am VERY uncomfortable with the Xanax use and am risking my medical license if we continue on this way." A subsequent email cautioned Patient P-1 that Xanax and Morphine were "a potentially dangerous combination". Respondent continued to prescribe these medications even after she learned that Patient P-1 had been psychiatrically committed.
12. By 2011, Respondent changed Patient P-1 from Xanax to Clonazepam based on Patient P-1's telephonic assertion that Xanax was no longer effective. The prescribing pattern continued in spite of an April 2011 notification from a pharmacy questioning the prescriptions and early refills, and in spite of a documented notation that "[p]atient has clearly over used [sic] the medication due to her severe depression and anxiety around her bereavement, unemployment and near homelessness."
13. By August 2011, Respondent'acquiesced to Patient P-1 's request to switch from Oxycodone to the more potent Oxycontin.
14. On December 12, 2011, Patient P-1 called Respondent and stated she wanted to try Seroquel again for sleep. Respondent prescribed Percocet and Seroquel along with Trazodone. Eleven days later, Patient P-1 called and requested Zoloft and Xanax which were prescribed along with Seroquel.
15. On February 29, 2012, Patient P-1 called and reported a "mental breakdown" and that she was having "falls due to back pain" and had some wounds forming from the falling. Respondent refilled her patient's medications including Trazodone 100 milligrams, Alprazolam (Xanax) 2 milligrams, Oxycodone-Acetaminophen (Percocet) 10/325 and Sertraline (Zoloft) 100 milligrams.
16. On March 26, 2012, Patient P-1 called Respondent to request an early refill of Xanax. Respondent complied and ordered the Xanax refilled early.
17. Respondent finally saw Patient P-1 one time on April 13, 2012. Respondent noted that her patient had "severe depression and chronic pain" and "is taking much more than prescribed dosage" of Xanax up to 8 per day "despite my warnings that this is too much for her". Respondent noted that the patient was positive for depression and suicidal ideas and negative for substance abuse. Nevertheless, Respondent continued prescribing controlled substances to Patient P-1 including Carisoprodol (Soma) 350 milligrams, Seroquel, Sertraline, Alprazolam (Xanax), Trazodone, Oxycodone-Acetaminophen (Percocet), and asthma medication.
18. On April 20, 2012, Patient P-1 called crying and in panic stating she was going through withdrawal, admitted to overuse and that was why she was running out early. The patient wanted more medicine as soon as possible and reported she was out of Percocet, Xanax and Soma. Respondent noted patient "really needs a psychiatrist" but had no resources to get one. The patient stated she had not slept for four days, was paranoid, had tremors, was hallucinating and seeing spiders when she goes outside. Respondent called in an early refill of Soma and Xanax and Zoloft.
19. On April 24, 2012, Patient P-1 called and said Hidden Valley Pharmacy would only give her one week of medication but that she had no car so very difficult to go back each week.
The patient claimed again that a roommate took all the medications of a three-month refill. Respondent assisted patient in changing her pharmacy and sent additional prescriptions to the new pharmacy.
20. On May 2, 2012, Patient P-1 called and was "depressed and crying" and wanted to restart Wellbutrin. Respondent told patient that she cannot give her more Xanax because she is already on "twice the recommended dose." Respondent prescribed 150 milligrams of Wellbutrin.
21. On May 11, 2012, Patient P-1 called "pretty agitated" and claimed having a panic attack and said she will run out ofTrazodone tomorrow, needed to be able to increase Percocet to 8 per day and needed Xanax. Respondent refilled Percocet and Trazodone.
22. On June 15, 2012, Patient P-1 advised by telephone she had a new address. Respondent ordered Trazodone 150 milligrams and Percocet sent to her new pharmacy, Coyote Pharmacy. On June 20, 2012, Respondent refilled prescriptions for Soma, Trazodone, Zoloft, Wellbutrin and Xanax.
23. On June 22, 2012 Respondent spoke to Patient P-1 for the last time who said she had not received her Percocet. Respondent sent her patient a month of Hydrocodone-Acetaminophen (Norco) 10/325 and refilled the Soma, Trazodone, Zoloft, Wellbutrin and Xanax.
24. Patient P-1 was found dead on July 1, 2012 from "acute oxycodone toxicity." Patient P-1 had a combination of alcohol, benzodiazepines, carisoprodol and opioids in her blood at the time of death.
CAUSE FOR DISCIPLINE
(Unprofessional Conduct: Gross Negligence, Repeated Negligent Acts, Incompetence and
Improper Prescribing Without an Appropriate Prior Examination and Medical Indication)
(Code Sections 2234(b),(c),(d) and 2242)
25. Respondent is subject to disciplinary action under section 2234, subdivisions (b)(gross negligence), (c)(repeated negligent acts), (d) (incompetence) and 2242 (improper prescribing) of the Code in that Respondent has committed gross negligence and/or repeated negligent acts and/or incompetence and/or improper prescribing without an appropriate prior examination and medical indication in the practice of medicine as described above, including, but not limited to, the following:
A. Respondent failed to adequately take a medical history and conduct a physical examination for multiple medical problems including, but not limited to, chronic pain, anxiety and depression, while prescribing controlled substances. The circumstances are described below:
After initial visits with Patient P-1, most of Respondent's care of her patient was done by 9 email or telephone, without a physical exam or personal encounter, including, but not limited to: ordering Xanax despite acknowledging it is "dangerous to mix with opiate pain medication"; refilling controlled substances including benzodiazepines and opioids; prescribing a new antidepressant to add to a current one; and refilling Percocet.
During the course of treatment, Respondent failed to perform adequate examinations or evaluation of her patient in person. Respondent prescribed combinations of controlled substances with a risk of overdose and death. Respondent only conducted a handful of face-to-face visits with many refills of prescriptions, Respondent continued to prescribe controlled substances and changed them with no physical exam. She prescribed early refills and antibiotics without seeing the patient. By the time of the patient's final physical exam, patient was overusing her medications and had asked for many early refills.
D. Respondent failed to adequately monitor the patient's safety while on combinations of controlled substances with a risk of overdose and death. The circumstances are described below:
Respondent prescribed controlled substances without adequate monitoring and surveillance. Respondent did not closely monitor her patient who was on a combination of controlled substances, some of them in high doses, while the patient had uncontrolled symptoms. Respondent was aware of the dangerous possible interactions between opioids and benzodiazepines, yet she prescribed them without seeing the patient in person. Respondent repeatedly gave early refills despite no physical examinations, based on the patient's request and a variety of excuses that should have been red flags for medication abuse. Respondent continued to refill prescriptions without a tapering plan despite recognizing the need for tapering.
Respondent acknowledged "risking (her) medical license" because of the high doses of Xanax she prescribed, and yet, Respondent prescribed even higher doses despite Patient P-1's promises to try to cut down. Respondent failed to refer her patient to the emergency room or to insist on a visit despite the patient complaining of withdrawal symptom, suffering from delirium tremens, and appearing to be in an altered state. Respondent prescribed a three-month supply of medications and prescribed Seroquel all at the patient's request when the patient stated that she had moved. Respondent continued to prescribe and change the combinations and doses of controlled substances, despite the patient not having health insurance through Kaiser, for over a year without a physical exam.
By the time Respondent saw her patient again after she obtained health insurance after a year and a half with no visits, her patient was overtaking benzodiazepines and was on a cocktail of medications that synergistically ran the risk of respiratory depression and death, including Xanax, Soma, Oxycodone, Trazodone and Seroquel. Respondent continued to prescribe these combinations of controlled substances despite her patient admitting to overusing, running out early and withdrawing from controlled substances. Respondent increased the doses at times without seeing her patient or referring her to the emergency room. Despite the patient's history of overuse of medications, Respondent appeared to. increase her patient's Percocet less than two months before her death. Towards the end of Patient P-1's life, she ran out of Percocet so Respondent prescribed a month supply of Hydrocodone-Acetaminophen (Norco), but then a week later the Percocet was refilled at the pharmacy. Despite worrying about the high doses of Xanax: and counseling her patient against increasing the dose of Xanax, Respondent still prescribed increasing doses: Respondent was concerned about patient's overuse of medications two years before her death, but continued to prescribe, at times, at increasing amounts despite prescribing more than the psychiatrist allowed. Despite acknowledging the risks and concerns related to overprescribing in combinations of drugs, Respondent did not adequately create a corresponding plan to address these concerns, such as tapering, referral to pain management, more frequent visits, or smaller prescription intervals.
______________________________________________________________________________________________________